Profusa, Inc. (PFSA)
NASDAQ: PFSA · Real-Time Price · USD
0.1770
-0.0045 (-2.48%)
At close: Dec 5, 2025, 4:00 PM EST
0.1769
-0.0001 (-0.06%)
After-hours: Dec 5, 2025, 7:59 PM EST
Profusa Revenue
In the year 2024, Profusa had annual revenue of $100.00K with 122.22% growth.
Revenue (ttm)
$100.00K
Revenue Growth
+122.22%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
15
Market Cap
11.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 100.00K | 55.00K | 122.22% |
| Dec 31, 2023 | 45.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 742.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionPFSA News
- 12 days ago - Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025 - GlobeNewsWire
- 17 days ago - Profusa Announces Third Quarter Business and Financial Highlights - GlobeNewsWire
- 5 weeks ago - Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches - GlobeNewsWire
- 5 weeks ago - Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026 - GlobeNewsWire
- 6 weeks ago - Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe - GlobeNewsWire
- 2 months ago - Profusa Invests Additional $1 Million in Digital Treasury Assets - GlobeNewsWire
- 2 months ago - Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base - GlobeNewsWire
- 3 months ago - Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring - GlobeNewsWire